- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/365 - Lactones
Détention brevets de la classe A61K 31/365
Brevets de cette classe: 2022
Historique des publications depuis 10 ans
166
|
175
|
155
|
176
|
146
|
166
|
180
|
136
|
137
|
62
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
The Regents of the University of California | 19812 |
33 |
The Board of Trustees of the Leland Stanford Junior University | 6365 |
24 |
Chengdu Baiyu Pharmaceutical Co., Ltd. | 70 |
21 |
Eisai R&D Management Co., Ltd. | 1233 |
15 |
Accendatech | 15 |
12 |
The Trustees of the University of Pennsylvania | 4308 |
11 |
Aphios Corporation | 43 |
11 |
Nankai University | 232 |
11 |
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 818 |
10 |
Sloan-Kettering Institute for Cancer Research | 508 |
10 |
Empros Pharma AB | 13 |
10 |
Synaptogenix, Inc. | 22 |
10 |
Wisconsin Alumni Research Foundation | 3864 |
9 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2837 |
9 |
Theravance Biopharma R&D IP, LLC | 462 |
9 |
Boehringer Ingelheim Animal Health USA Inc. | 416 |
9 |
Novartis AG | 10904 |
8 |
The Johns Hopkins University | 5642 |
8 |
Northwestern University | 3364 |
8 |
Everfront Biotech Inc. | 12 |
8 |
Autres propriétaires | 1776 |